The Infectious Diseases Society of America proposed a new approval option for companies interested in developing drugs to treat patients with serious infections where few or no treatment options exist.
Read the full report in Becker’s Hospital Review on IDSA’s proposal to the House Energy and Commerce Committee Subcommittee on Health.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
